Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Th Schreuder
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Genes & Molecular Sequences
Procedures
Concepts & Ideas
Physiology
Disorders
Geographic Areas
Sign-in to see full Profile
Network (preview)
25
De Vries, René
24
van Rood, Jon
21
Persijn, Guido
20
Breedveld, Ferdinand
19
Giphart, Marius
18
Bontrop, Ronald
18
Albert, Ekkehard
17
Bodmer, Walter
17
Dupont, Bo
17
Erlich, Henry
17
Sasazuki, Takehiko
17
Strominger, Jack
17
Svejgaard, Arne
17
Terasaki, Paul
17
Mach, Bernard
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Th Schreuder (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2008: de Vries-Bouwstra J K; Goekoop-Ruiterman Y P M; Verpoort K N; Schreuder G M T; Ewals J A P M; Terwiel J P; Ronday H K; Kerstens P J S M; Toes R E M; de Vries R R P; Breedveld F C; Dijkmans B A C; Huizinga T W J; Allaart C F
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
Arthritis and rheumatism 2008;58(5):1293-8.
-
2006: Riemersma S A; Jordanova E S; Haasnoot G W; Drabbels J; Schuuring E; Schreuder G M T; Kluin Ph M
The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.
Human immunology 2006;67(4-5):303-10.
-
2006: Maat Willem; Haasnoot Geert W; Claas Frans H J; Schalij-Delfos Nicoline E; Schreuder Geziena M T; Jager Martine J
HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Investigative ophthalmology & visual science 2006;47(1):3-6.
-
2005: Huizinga Tom W J; Amos Christopher I; van der Helm-van Mil Annette H M; Chen Wei; van Gaalen Floris A; Jawaheer Damini; Schreuder Geziena M T; Wener Mark; Breedveld Ferdinand C; Ahmad Naila; Lum Raymond F; de Vries Rene R P; Gregersen Peter K; Toes Rene E M; Criswell Lindsey A
Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Arthritis and rheumatism 2005;52(11):3433-8.
-
2005: Verpoort Kirsten N; van Gaalen Floris A; van der Helm-van Mil Annette H M; Schreuder Geziena M T; Breedveld Ferdinand C; Huizinga Tom W J; de Vries Rene R P; Toes Rene E M
Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
Arthritis and rheumatism 2005;52(10):3058-62.
-
2005: van der Helm-van Mil Annette H M; Huizinga Tom W J; Schreuder Geziena M Th; Breedveld Ferdinand C; de Vries René R P; Toes René E M
An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.
Arthritis and rheumatism 2005;52(9):2637-44.
-
2005: Marsh Steven G E; Albert Ekkehard D; Bodmer Walter F; Bontrop Ronald E; Dupont Bo; Erlich Henry A; Geraghty Daniel E; Hansen John A; Hurley Carolyn K; Mach Bernard; Mayr Wolfgang R; Parham Peter; Petersdorf Effie W; Sasazuki Takehiko; Schreuder Geziena M Th; Strominger Jack L; Svejgaard Arne; Terasaki Paul I; Trowsdale John
Nomenclature for Factors of the HLA System, 2004.
Human immunology 2005;66(5):571-636.
-
2005: Marsh S G E; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Geraghty D E; Hansen J A; Hurley C K; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M Th; Strominger J L; Svejgaard A; Terasaki P I; Trowsdale J
Nomenclature for factors of the HLA system, 2004.
Tissue antigens 2005;65(4):301-69.
-
2005: Marsh S G E; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Geraghty D E; Hansen J A; Hurley C K; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M Th; Strominger J L; Svejgaard A; Terasaki P I; Trowsdale J
Nomenclature for factors of the HLA system, 2004.
International journal of immunogenetics 2005;32(2):107-59.
-
2005: Schreuder Geziena M Th; Hurley Carolyn K; Marsh Steven G E; Lau Marie; Fernandez-Vina Marcelo A; Noreen Harriet J; Setterholm Michelle; Maiers Martin
HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
Human immunology 2005;66(2):170-210.
-
2005: Schreuder G M Th; Hurley C K; Marsh S G E; Lau M; Fernandez-Vina M; Noreen H J; Setterholm M; Maiers M
The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
International journal of immunogenetics 2005;32(1):19-69.
-
2005: Schreuder G M Th; Hurley C K; Marsh S G E; Lau M; Fernandez-Vina M; Noreen H J; Setterholm M; Maiers M;
The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
Tissue antigens 2005;65(1):1-55.
-
2005: Geleijns K; Schreuder G M Th; Jacobs B C; Sintnicolaas K; van Koningsveld R; Meulstee J; Laman J D; van Doorn P A
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.
Neurology 2005;64(1):44-9.
-
2004: Badrising U A; Schreuder G M Th; Giphart M J; Geleijns K; Verschuuren J J G M; Wintzen A R; Maat-Schieman M L C; van Doorn P; van Engelen B G M; Faber C G; Hoogendijk J E; de Jager A E; Koehler P J; de Visser M; van Duinen S G;
Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.
Neurology 2004;63(12):2396-8.
-
2004: van Gaalen Floris A; van Aken Jill; Huizinga Tom W J; Schreuder Geziena M Th; Breedveld Ferdinand C; Zanelli Eric; van Venrooij Walther J; Verweij Cornelis L; Toes René E M; de Vries René R P
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
Arthritis and rheumatism 2004;50(7):2113-21.
-
2004: de Vijlder Hannah C; Westerhof Wiete; Schreuder Geziena M Th; de Lange Peter; Claas Frans H J
Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study.
Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2004;17(3):270-4.
-
2004: Anholts J D H; Drabbels J; Verduijn W; Oudshoorn M; Schreuder G M Th
Five newly identified HLA alleles: A*0310, A*2907, B*4435, Cw*0206, Cw*0506, and confirmation of A*3106, B*3924, Cw*0314, DRB1*0322, and DRB1*1433 alleles.
Tissue antigens 2004;63(1):80-4.
-
2003: Witter K; Lau M; Schreuder G M Th; Albert E D
A novel B*38 allele, B*3809, was identified via sequence -based typing of B-cell line no. 299 of the UCLA International Cell Exchange.
Tissue antigens 2003;62(6):548-50.
-
2003: Maiers M; Schreuder G M T; Lau M; Marsh S G E; Fernandez-Viña M; Noreen H; Setterholm M; Katovich Hurley C
Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products.
Tissue antigens 2003;62(1):21-47.
-
2003: Duquesnoy Rene J; Takemoto Steve; de Lange Peter; Doxiadis Ilias I N; Schreuder Geziena M Th; Persijn Guido G; Claas Frans H J
HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Transplantation 2003;75(6):884-9.
-
2003: Riyazi N; Spee J; Huizinga T W J; Schreuder G M T; de Vries R R P; Dekker F W; Kloppenburg M
HLA class II is associated with distal interphalangeal osteoarthritis.
Annals of the rheumatic diseases 2003;62(3):227-30.
-
2003: Kessler Jan H; Mommaas Bregje; Mutis Tuna; Huijbers Ivo; Vissers Debby; Benckhuijsen Willemien E; Schreuder Geziena M Th; Offringa Rienk; Goulmy Els; Melief Cornelis J M; van der Burg Sjoerd H; Drijfhout Jan W
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.
Human immunology 2003;64(2):245-55.
-
2003: Völker-Dieben H J; Schreuder G M Th; Claas F H J; Doxiadis I I N; Schipper R F; Pels E; Persijn G G; Smits J; D'Amaro J
Histocompatibility and corneal transplantation.
Developments in ophthalmology 2003;36():22-41.
-
2002: Marsh Steven G E; Albert Ekkehard D; Bodmer Walter F; Bontrop Ronald E; Dupont Bo; Erlich Henry A; Geraghty Daniel E; Hansen John A; Mach Bernard; Mayr Wolfgang R; Parham Peter; Petersdorf Effie W; Sasazuki Takehiko; Schreuder Geziena M T; Strominger Jack L; Svejgaard Arne; Terasaki Paul I
Nomenclature for factors of the HLA system, 2002.
Human immunology 2002;63(12):1213-68.
-
2002: Marsh Steven G E; Albert Ekkehard D; Bodmer Walter F; Bontrop Ronald E; Dupont Bo; Erlich Henry A; Geraghty Daniel E; Hansen John A; Mach Bernard; Mayr Wolfgang R; Parham Peter; Petersdorf Effie W; Sasazuki Takehiko; Schreuder Geziena M Th; Strominger Jack L; Svejgaard Arne; Terasaki Paul I
Nomenclature for factors of the HLA system, 2002.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2002;29(6):463-515.
-
2002: Marsh S G E; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Geraghty D E; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M Th; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2002.
Tissue antigens 2002;60(5):407-64.
-
2002: Tiercy J-M; Marsh S G E; Schreuder G M Th; Albert E; Fischer G; Wassmuth R;
Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2002;29(3):273-4.
-
2002: Visser H; Vos K; Zanelli E; Verduyn W; Schreuder G M Th; Speyer I; Breedveld F C; Hazes J M W
Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.
Annals of the rheumatic diseases 2002;61(6):499-504.
-
2002: Lard L R; Boers M; Verhoeven A; Vos K; Visser H; Hazes J M W; Zwinderman A H; Schreuder G M T; Breedveld F C; De Vries R R P; van der Linden S; Zanelli E; Huizinga T W J
Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage.
Arthritis and rheumatism 2002;46(4):899-905.
-
2002: Molenaar E T H; Voskuyl A E; van der Horst-Bruinsma I E; Schreuder G M Th; Zanelli E; Dijkmans B A C
Influence of HLA polymorphism on persistent remission in rheumatoid arthritis.
Annals of the rheumatic diseases 2002;61(4):351-3.
-
2002: Brouwer Rolf E; van der Heiden Pim; Schreuder Geziena M T; Mulder Arend; Datema Gert; Anholts Jacqy D H; Willemze Roel; Claas Frans H J; Falkenburg J H Frederik
Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon.
Human immunology 2002;63(3):200-10.
-
2002: Pascual M; Matarán L; Jones G; Shing D; van der Slik A R; Giphart M J; Schreuder G M Th; de Vries R R P; Breedveld F C; Roovers E; Zanelli E; Martin J
HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes.
Scandinavian journal of rheumatology 2002;31(5):275-8.
-
2001: Schreuder G M; Hurley C K; Marsh S G; Lau M; Maiers M; Kollman C; Noreen H J
The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2001;28(6):565-96.
-
2001: van der Linden M W; van der Slik A R; Zanelli E; Giphart M J; Pieterman E; Schreuder G M; Westendorp R G; Huizinga T W
Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus.
Genes and immunity 2001;2(7):373-80.
-
2001: Vos K; Visser H; Schreuder G M; de Vries R R; Zwinderman A H; Breedveld F C; Hazes J M; Zanelli E H
Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone.
Human immunology 2001;62(11):1217-25.
-
2001: Schreuder G M; Hurley C K; Marsh S G; Lau M; Maiers M; Kollman C; Noreen H J
The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
Tissue antigens 2001;58(2):109-40.
-
2001: Schreuder G M; Hurley C K; Marsh S G; Lau M; Maiers M; Kollman C; Noreen H J
The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
Human immunology 2001;62(8):826-49.
-
2001: Wirtz P W; Roep B O; Schreuder G M; van Doorn P A; van Engelen B G; Kuks J B; Twijnstra A; de Visser M; Visser L H; Wokke J H; Wintzen A R; Verschuuren J J
HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.
Human immunology 2001;62(8):809-13.
-
2001: Anholts J D; Kemps-Mols B; Verduijn W; Oudshoorn M; Schreuder G M
Three newly identified HLA-B alleles: B*5124, B*5306, B*5307 and confirmation of B*0809 and B*5606.
Tissue antigens 2001;58(1):38-41.
-
2001: Marsh S G; Bodmer J G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; MacH B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2000.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 2001;28(3):377-424.
-
2001: Middleton D; Curran M D; Anholts J D; Reilly E R; Schreuder G M
Characterisation of a new HLA-B allele, HLA-B*0724.
Tissue antigens 2001;57(5):471-3.
-
2001: Mulder A; Kardol M J; Kamp J; Uit Het Broek C; Schreuder G M; Doxiadis I I; Claas F H
Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals.
Clinical and experimental immunology 2001;124(1):9-15.
-
2001: Marsh S G; Bodmer J G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2000.
Human immunology 2001;62(4):419-68.
-
2001: Snijders A; Elferink D G; Geluk A; van Der Zanden A L; Vos K; Schreuder G M; Breedveld F C; de Vries R R; Zanelli E H
An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(8):4987-93.
-
2001: Marsh S G; Bodmer J G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 2000.
Tissue antigens 2001;57(3):236-83.
-
2001: Schipper R F; Koeleman B P; Bruining G J; Schreuder G M; Verduijn W; De Vries R R; Roep B O
HLA class II associations with Type 1 diabetes mellitus: a multivariate approach.
Tissue antigens 2001;57(2):144-50.
-
2001: Vos K; van der Horst-Bruinsma I E; Hazes J M; Breedveld F C; le Cessie S; Schreuder G M; de Vries R R; Zanelli E
Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis.
Rheumatology (Oxford, England) 2001;40(2):133-9.
-
2001: Zanelli E; Jones G; Pascual M; Eerligh P; van der Slik A R; Zwinderman A H; Verduyn W; Schreuder G M; Roovers E; Breedveld F C; de Vries R R; Martin J; Giphart M J
The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci.
Human immunology 2001;62(1):75-84.
-
2000: Völker-Dieben H J; Claas F H; Schreuder G M; Schipper R F; Pels E; Persijn G G; Smits J; D'Amaro J
Beneficial effect of HLA-DR matching on the survival of corneal allografts.
Transplantation 2000;70(4):640-8.
-
2000: Anholts J D; Verduijn W; Drabbels J; Mulder A; Doxiadis I I; Schreuder G M
Identification of two new alleles HLA-DRB1*0312, DRB1*0432 and of a DRB3-negative DRB1*1313-positive haplotype.
Tissue antigens 2000;56(1):87-9.
-
2000: Hristova-Dimceva A; Verduijn W; Schipper R F; Schreuder G M
HLA-DRB and -DQB1 polymorphism in the Macedonian population.
Tissue antigens 2000;55(1):53-6.
-
2000: Rood M J; van Krugten M V; Zanelli E; van der Linden M W; Keijsers V; Schreuder G M; Verduyn W; Westendorp R G; de Vries R R; Breedveld F C; Verweij C L; Huizinga T W
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.
Arthritis and rheumatism 2000;43(1):129-34.
-
2000: Doxiadis I I; Witvliet M; Verduyn W; de Lange P; Tanke J; Schreuder G M; Persijn G G; Claas F H
The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
Clinical transplants 2000;():99-103.
-
1999: Schreuder G M; Hurley C K; Marsh S G; Lau M; Maiers M; Kollman C; Noreen H
The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
Human immunology 1999;60(11):1157-81.
-
1999: Schreuder G M; Hurley C K; Marsh S G; Lau M; Maiers M; Kollman C; Noreen H
The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
Tissue antigens 1999;54(4):409-37.
-
1999: Roep B O; Schipper R; Verduyn W; Bruining G J; Schreuder G M; de Vries R R
HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype.
Tissue antigens 1999;54(1):88-90.
-
1999: Thole J E; Janson A A; Cornelisse Y; Schreuder G M; Wieles B; Naafs B; de Vries R R; Ottenhoff T H
HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(11):6912-8.
-
1999: Posthuma E F; Falkenburg J H; Apperley J F; Gratwohl A; Roosnek E; Hertenstein B; Schipper R F; Schreuder G M; D'Amaro J; Oudshoorn M; van Biezen J H; Hermans J; Willemze R; Niederwieser D
HLA-B8 and HLA-A3 coexpressed with HLA-B8 are associated with a reduced risk of the development of chronic myeloid leukemia. The Chronic Leukemia Working Party of the EBMT.
Blood 1999;93(11):3863-5.
-
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA System, 1998.
Human immunology 1999;60(4):361-95.
-
1999: Krul E J; Schipper R F; Schreuder G M; Fleuren G J; Kenter G G; Melief C J
HLA and susceptibility to cervical neoplasia.
Human immunology 1999;60(4):337-42.
-
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1998.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1999;26(2-3):81-116.
-
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1998.
Tissue antigens 1999;53(4 Pt 2):407-46.
-
1999: Ressing M E; de Jong J H; Brandt R M; Drijfhout J W; Benckhuijsen W E; Schreuder G M; Offringa R; Kast W M; Melief C J
Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.
European journal of immunology 1999;29(4):1292-303.
-
1999: van der Horst-Bruinsma I E; Visser H; Hazes J M; Breedveld F C; Verduyn W; Schreuder G M; de Vries R R; Zanelli E
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis.
Human immunology 1999;60(2):152-8.
-
1999: Bouma G; Crusius J B; García-González M A; Meijer B U; Hellemans H P; Hakvoort R J; Schreuder G M; Kostense P J; Meuwissen S G; Peña A S
Genetic markers in clinically well defined patients with ulcerative colitis (UC).
Clinical and experimental immunology 1999;115(2):294-300.
-
1999: van der Horst-Bruinsma I E; Huizinga T W; Lagaay E M; Hazes J M; Breedveld F C; Schreuder G M; Tomson T A; Zwinderman A H; van Rood J J; de Vries R R
The influence of a partially HLA-matched blood transfusion on the disease activity of rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(1):53-8.
-
1999: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Dupont B; Erlich H A; Hansen J A; Mach B; Mayr W R; Parham P; Petersdorf E W; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1998.
Vox sanguinis 1999;77(3):164-91.
-
1998: van der Horst-Bruinsma I E; Hazes J M; Schreuder G M; Radstake T R; Barrera P; van de Putte L B; Mustamu D; van Schaardenburg D; Breedveld F C; de Vries R R
Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis.
Annals of the rheumatic diseases 1998;57(11):672-5.
-
1998: Zanelli E; Huizinga T W; Guerne P A; Vischer T L; Tiercy J M; Verduyn W; Schreuder G M; Breedveld F C; de Vries R R
An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition.
Immunogenetics 1998;48(6):394-401.
-
1998: Schipper R F; D'Amaro J; de Lange P; Schreuder G M; van Rood J J; Oudshoorn M
Validation of haplotype frequency estimation methods.
Human immunology 1998;59(8):518-23.
-
1998: van der Horst-Bruinsma I E; de Vries R R; de Buck P D; van Schendel P W; Breedveld F C; Schreuder G M; Hazes J M
Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother.
Annals of the rheumatic diseases 1998;57(5):286-90.
-
1998: Bouma G; Poen A C; García-González M A; Schreuder G M; Felt-Bersma R J; Meuwissen S G; Pena A S
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease.
Immunogenetics 1998;47(6):451-5.
-
1997: Yazdanbakhsh M; Abadi K; de Roo M; van Wouwe L; Denham D; Medeiros F; Verduijn W; Schreuder G M; Schipper R; Giphart M J; de Vries R R
HLA and elephantiasis revisited.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1997;24(6):439-42.
-
1997: Oudshoorn M; Cornelissen J J; Fibbe W E; de Graeff-Meeder E R; Lie J L; Schreuder G M; Sintnicolaas K; Willemze R; Vossen J M; van Rood J J
Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
Bone marrow transplantation 1997;20(12):1011-7.
-
1997: Hurley C K; Schreuder G M; Marsh S G; Lau M; Middleton D; Noreen H
The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens.
Tissue antigens 1997;50(4):401-18.
-
1997: Bouma G; Oudkerk Pool M; Crusius J B; Schreuder G M; Hellemans H P; Meijer B U; Kostense P J; Giphart M J; Meuwissen S G; Peña A S
Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
Clinical and experimental immunology 1997;109(1):175-9.
-
1997: Brinkman B M; Huizinga T W; Kurban S S; van der Velde E A; Schreuder G M; Hazes J M; Breedveld F C; Verweij C L
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?
British journal of rheumatology 1997;36(5):516-21.
-
1997: Voskuyl A E; Hazes J M; Schreuder G M; Schipper R F; de Vries R R; Breedveld F C
HLA-DRB1, DQA1, and DQB1 genotypes and risk of vasculitis in patients with rheumatoid arthritis.
The Journal of rheumatology 1997;24(5):852-5.
-
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1996.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1997;24(2):105-51.
-
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA System, 1996.
Human immunology 1997;53(1):98-128.
-
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1996.
Tissue antigens 1997;49(3 Pt 2):297-321.
-
1997: Doxiadis I I; de Lange P; D'Amaro J; de Meester J; Schreuder G M; Claas F H
Repeated HLA mismatches in cadaveric renal transplantation: is it safe to transplant?
Transplantation proceedings 1997;29(1-2):1408-9.
-
1997: Voorter C E; de Bruyn-Geraets D; Verduyn W; Schreuder G M; van den Berg-Loonen E M
Identification of a new HLA-DRB1*13 allele (DRB1*1326) with a short DRB1*16 sequence.
Tissue antigens 1997;49(1):88-91.
-
1997: Bodmer J G; Marsh S G; Albert E D; Bodmer W F; Bontrop R E; Charron D; Dupont B; Erlich H A; Fauchet R; Mach B; Mayr W R; Parham P; Sasazuki T; Schreuder G M; Strominger J L; Svejgaard A; Terasaki P I
Nomenclature for factors of the HLA system, 1996.
Vox sanguinis 1997;73(2):105-30.
-
1996: Schipper R F; Schreuder G M; D'Amaro J; Oudshoorn M
HLA gene and haplotype frequencies in Dutch blood donors.
Tissue antigens 1996;48(5):562-74.
-
1996: Doxiadis I I; Smits J M; Schreuder G M; Persijn G G; van Houwelingen H C; van Rood J J; Claas F H
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.
Lancet 1996;348(9031):850-3.
-
1996: Verduyn W; Anholts J D; Versluis L F; Parlevliet J; Drabbels J; De Meester J; Tilanus M G; Doxiadis I I; Giphart M J; Schreuder G M
Six newly identified HLA-DRB alleles: DRB1*1121, *1419, *1420, *1421, DRB3*0203 and DRB5*0103.
Tissue antigens 1996;48(2):80-6.
-
1996: Roep B O; Duinkerken G; Schreuder G M; Kolb H; de Vries R R; Martin S
HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus.
European journal of immunology 1996;26(6):1285-9.
-
1996: Bouma G; Crusius J B; Oudkerk Pool M; Kolkman J J; von Blomberg B M; Kostense P J; Giphart M J; Schreuder G M; Meuwissen S G; Peña A S
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.
Scandinavian journal of immunology 1996;43(4):456-63.
-
1996: Anholts J D; Bouwens A G; Verduyn W; Tilanus M G; Schreuder G M
Sequence of HLA-DRB 1*1606 is incorrect.
Human immunology 1996;46(1):65-6.
-
1996: Zantvoort F A; D'Amaro J; Persijn G G; Cohen B; Schreuder G M; Van Rood J J; Thorogood J
The impact of HLA-A matching on long-term survival of renal allografts.
Transplantation 1996;61(5):841-4.
-
1996: Doxiadis I I; Smits J M; Stobbe I; Schreuder G M; Persijn G G; van Houwelingen H; van Rood J J; Claas F H
Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
Transplantation proceedings 1996;28(1):224.
-
1996: Ressing M E; van Driel W J; Celis E; Sette A; Brandt M P; Hartman M; Anholts J D; Schreuder G M; ter Harmsel W B; Fleuren G J; Trimbos B J; Kast W M; Melief C J
Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.
Cancer research 1996;56(3):582-8.
-
1996: Bouwens-Rombouts A G; Verduyn W; Versluis L F; Schreuder G M; Tilanus M G; Giphart M
HLA-DRB1*04 high resolution typing.
Experimental and clinical immunogenetics 1996;13(2):84-91.
-
1995: Termijtelen A; D'Amaro J; van Rood J J; Schreuder G M
Linkage disequilibrium in HLA cannot be explained by selective recombination.
Tissue antigens 1995;46(5):387-90.
-
1995: Anholts J D; Verduyn W; Parlevliet A; Doxiadis I I; D'Amaro J; Giphart M J; Persijn G G; Schreuder G M
Irregular polymerase chain reaction-sequence-specific oligonucleotide hybridization patterns reveal seven new HLA-DRB1 alleles related to DR2, DR3, DR6, DR8, and DR11. Implications for sequence-specific priming.
Human immunology 1995;42(1):15-22.
-
1995: van Lochem E G; Schreuder G M; Tilanus M G; de Gast G C; Goulmy E
Dendritic cells induce HLA-DP-specific T-cell proliferation between MLR-negative siblings.
Immunogenetics 1995;41(2-3):134-8.
-
1993: Thorogood J; Doxiadis I I; Schreuder G M; Persijn G G; van Rood J J
Survival of serologically HLA typed and matched cadaveric kidney transplants and patients: influence of serologic retyping of donors.
Transplantation proceedings 1993;25(6):3051-2.
-
1993: Thorogood J; Schreuder G M; Persijn G G; van Rood J J
Organ sharing based on HLA matching saves dialysis years and patient lives.
Transplantation proceedings 1993;25(6):3049-50.
-
1993: Verduyn W; Doxiadis I I; Anholts J; Drabbels J J; Naipal A; D'Amaro J; Persijn G G; Giphart M J; Schreuder G M
Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant.
Human immunology 1993;37(1):59-67.
-
1993: ten Wolde S; Breedveld F C; de Vries R R; D'Amaro J; Rubenstein P; Schreuder G M; Claas F H; van Rood J J
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis.
Lancet 1993;341(8839):200-2.
-
1993: Schreuder G M; Pool J; Blokland E; van Els C; Bakker A; van Rood J J; Goulmy E
A genetic analysis of human minor histocompatibility antigens demonstrates Mendelian segregation independent of HLA.
Immunogenetics 1993;38(2):98-105.
-
1992: Thorogood J; Schreuder G M; Persijn G G; van Rood J J
Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
Transplantation proceedings 1992;24(6):2485-7.
-
1992: Thorogood J; van Houwelingen J C; van Rood J J; Zantvoort F A; Schreuder G M; Persijn G G
Factors contributing to long-term kidney graft survival in Eurotransplant.
Transplantation 1992;54(1):152-8.
-
1992: Schroeijers W E; de Koster H S; Verduyn W; Schreuder G M; Termijtelen A
T-cell recognition of class II products that result from the combined presence of two different HLA haplotypes.
Human immunology 1992;33(4):229-34.
-
1992: Thorogood J; van Houwelingen J C; van Rood J J; Zantvoort F A; Schreuder G M; Persijn G G
Factors affecting the long-term outcome following non-living kidney transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S138-9.
-
1991: Thorogood J; Houwelingen J C; Persijn G G; Zantvoort F A; Schreuder G M; van Rood J J
Prognostic indices to predict survival of first and second renal allografts.
Transplantation 1991;52(5):831-6.
-
1991: Schreuder G M; van den Berg-Loonen P M; Verduyn W; Geraets D P; Parlevliet J; van Rood J J; Giphart M J
Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
Human immunology 1991;32(2):141-9.
-
1991: Thorogood J; van Houwelingen J C; Persijn G G; Zantvoort F A; Schreuder G M; van Rood J J
Prognostic indices for first and second transplants can predict kidney graft survival.
Transplantation proceedings 1991;23(1 Pt 2):1330-1.
-
1990: Thorogood J; Persijn G G; Schreuder G M; D'Amaro J; Zantvoort F A; van Houwelingen J C; van Rood J J
The effect of HLA matching on kidney graft survival in separate posttransplantation intervals.
Transplantation 1990;50(1):146-50.
-
1990: Vijverberg K; Schreuder G M; Kenter M J; Naipal A M; van Rood J J; Giphart M J
Applicability of HLA-DQB oligonucleotide typing for the TA10 and 2B3 specificities in routine HLA typing.
Tissue antigens 1990;35(4):165-71.
-
1989: Persijn G G; D'Amaro J; de Lange P; Schreuder G M; van Rood J J
Modulation of the HLA-A, -B, -DR matching effect by cyclosporin therapy.
Transplantation proceedings 1989;21(1 Pt 1):656-8.
-
1989: Kenter M J; Anholts J D; Schreuder G M; van Eggermond M C; Ghyselen G M; van Rood J J; Giphart M J
Unambiguous typing for HLA-DQ TA10 and 2B3 specificities using specific oligonucleotide probes.
Human immunology 1989;24(1):65-73.
-
1989: Tilanus M G; van Eggermond M C; Fei H M; Schreuder G M; Giphart M J
A family with an apparent HLA-DR triplet: evidence for exchange of functional HLA-DR beta-genes between different haplotypes.
Experimental and clinical immunogenetics 1989;6(2):162-8.
-
1988: Persijn G G; D'Amaro J; De Lange P; Schreuder G M; Thorogood J; Zantvoort F; Van Rood J J
The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
Clinical transplants 1988;():237-48.
-
1987: Tilanus M G; Van Eggermond M C; Fei H; D'Amaro J; Schreuder G M; Giphart M J
RFLP of the HLA-DQ alpha region: a diallelic DX alpha polymorphism, not linked to DR and DQ specificities.
Tissue antigens 1987;30(3):128-34.
-
1987: Tilanus M G; van Eggermond M C; van der Bijl M; Morolli B; Schreuder G M; De Vries R R; Giphart M J
HLA class II DNA analysis by RFLP reveals novel class II polymorphism.
Human immunology 1987;18(4):265-76.
-
1987: Hendriks G F; de Lange P; Schreuder G M; D'Amaro J; Persijn G G; van Rood J J
The impact of cyclosporine A on the DRw6 effect in renal transplantation.
Transplantation proceedings 1987;19(1 Pt 1):650-1.
-
1986: Tilanus M G; Hongming F; van Eggermond M C; vd Bijl M; D'Amaro J; Schreuder G M; de Vries R R; Giphart M J
An overview of the restriction fragment length polymorphism of the HLA-D region: its application to individual D-, DR- typing by computerized analyses.
Tissue antigens 1986;28(4):218-27.
-
1986: Tilanus M G; Morolli B; van Eggermond M C; Schreuder G M; de Vries R R; Giphart M J
Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.
Immunogenetics 1986;23(5):333-40.
-
1985: Bosch M L; Schreuder G M; Spits H; Termijtelen A; Tilanus M G; Giphart M J
Polymorphisms within the HLA-DRw6 haplotype. I. Restriction fragment length variation and its correlation with serology.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(5):3212-7.
-
1985: Hendriks G F; de Lange P; D'Amaro J; Schreuder G M; Claas F H; Persijn G G; van Rood J J
Eurotransplant experience with highly immunized patients.
Scandinavian journal of urology and nephrology. Supplementum 1985;92():81-6.
-
1985: Bosch M L; Termijtelen A; Gerrets R; Schreuder G M; Bontrop R E; Giphart M J
Polymorphisms within the HLA-DRw6 haplotype. II. Protein charge heterogeneity reflects MLC subtyping of HLA-DRw6 homozygous cells.
Immunogenetics 1985;22(1):23-33.
Sign-in to see more